Hexima Limited (ASX:HXL)

Market Cap	2.17M
Revenue (ttm)	n/a
Net Income (ttm)	-955.58K
Shares Out	167.04M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,800
Average Volume	22,011
Open	0.0130
Previous Close	0.0130
Day's Range	0.0130 - 0.0130
52-Week Range	0.0080 - 0.0230
Beta	0.86
RSI	16.18
Earnings Date	May 29, 2025

About Hexima

Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company’s assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.

• Industry: Shell Companies
• Sector: Financials
• Founded: 1997
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HXL

Financial Performance

In 2024, Hexima's revenue was 61,674, a decrease of -95.85% compared to the previous year's 1.49 million. Losses were -933,873, -51.33% less than in 2023.